Science Writer & Editor
at Technology Networks
Alexander is a science writer and editor for Technology Networks. He writes news and features for the Applied Sciences section, leading the site's coverage of topics relating to materials science and engineering.
Before joining Technology Networks in 2023, Alexander worked as a freelance science writer, reporting on a broad range of topics including cannabis science and policy, psychedelic drug research and environmental science. He holds a masters degree in Materials Chemistry from the University of St Andrews, Scotland.Education
Awards & Certifications
Chemistry Purdie scholarship awarded by the University of St Andrews · August 2013
Areas of Expertise
Got a Question for Alexander Beadle?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 275
Article
Israeli Firm Commercializes Cannabis Testing “Lab-on-a-desk”
The analyzer is a hybrid testing machine which combines the use of near-infrared spectroscopy technology with visual image analysis and machine learning to accurately characterize the potency of a cannabis sample.
Article
Cannabis Genome Mapping Beats Human Genome Project Benchmark
A team at Medicinal Genomics have successfully sequenced the cannabis genome at 640kb N50, representing a 28% improvement on the Human Genome Project standard.
Article
Washington State Prepares for Cannabis Testing and Packaging Law Reform
A list of the proposed rule changes is expected to be published on or after October 31 2018 and will address issues like THC serving limits, packaging requirements, and contaminant testing.
Article
First Ever Cannabis Product Recalls Announced in California
The first voluntary product recall in California was initiated by the vape cartridge manufacturer, The Bloom Brand, on July 25 and the second by Lowell Herb Co. concerning a batch of their pre-rolled cannabis cigarettes.
Article
Combining CBD with Chemotherapy Posts Promising Results in Pancreatic Cancer Model
Mice who received a combination of CBD and chemotherapy survived nearly three times as long as the mice given the placebo, and around twice as long as the mice given CBD or chemotherapy alone.
Article
Variable Accumulation of Bioactive Metabolites Revealed in Medicinal Cannabis
Across four distinct strains it was observed that the flower samples taken from the upper third of the plant had a higher THC content than those at the base of the plant, and in two of the strains tested the difference was equivalent to the upper flowers being around twice as potent as the lower flowers.
Article
Californian Cannabis Industry Hit by Wildfires
In addition to losses from direct burning as wildfires spread, soot is holding back plant growth whilst fire-borne contaminants continue to pose a risk to consumers.
Article
British Government Set to Loosen Rules on Medicinal Cannabis
The changes concern the reclassification of cannabis to make it a schedule 2 drug, allowing it to be prescribed by medical professionals and possessed lawfully by anybody with a valid medical prescription.
Article
Techniques and Technologies for Microbiological Contamination Testing
The accurate detection of microbial contamination is key to protecting consumer safety and, helping to reduce the environmental burden of pesticide use in the cannabis industry.
Article
Removing Purple Pigments from Cannabis Prior to Analysis
Novel sample prep blend enables an average recovery of 75.6% for 48 pesticides and 4 mycotoxins whilst also removing purple pigmentation from cannabis samples.
Advertisement
